Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

References

• Zittoun R A, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217–223
   PubMed Web of Science ®Google Scholar
• Dann E J, Daugherty C K, Larson R A. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 20: 369–374
   PubMed Web of Science ®Google Scholar
• Verdonck L F, Dekker A W, Lokhorst H M, Petersen E J, Nieuwenhuis H K. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 4201–4205
   PubMed Web of Science ®Google Scholar
• Rehman Q, Lane N E. Effect of glucocorticoids on bone density. Med Pediatr Oncol 2003; 41: 212–216
   PubMedGoogle Scholar
• Theiler R, Kranzlin M, Zynamon A, Tyndall A, Schmid H P. High-turnover osteoporosis and diffuse idiopathic skeletal hyperostosis induced by retinoid therapy in a patient with superficial bladder cancer. Br J Urol 1995; 76: 400–401
   PubMedGoogle Scholar
• Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003; 14: 617–630
   PubMed Web of Science ®Google Scholar
• Bush N E, Donaldson G W, Haberman M H, Dacanay R, Sullivan K M. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591
   PubMed Web of Science ®Google Scholar
• Banfi A, Bianchi G, Galotto M, Cancedda R, Quarto R. Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment. Leuk Lymphoma 2001; 42: 863–870
   PubMed Web of Science ®Google Scholar
• Rivkees S A, Crawford J D. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988; 259: 2123–2125
   PubMed Web of Science ®Google Scholar
• Ferretti J L, Cointry G R, Capozza R F, Frost H M. Bone mass, bone strength, muscle-bone interactions, osteopenias and osteoporoses. Mech Ageing Dev 2003; 124: 269–279
   PubMed Web of Science ®Google Scholar
• Adami S, Giannini S, Giorgino R, Isaia G C, Maggi S, Sinigaglia L, et al. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 2003; 14: 198–207
   PubMed Web of Science ®Google Scholar
• Diamond T, Levy S, Day P, Barbagallo S, Manoharan A, Kwan Y K. Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity. Br J Haematol 1997; 97: 641–648
   PubMed Web of Science ®Google Scholar
• Schulte C, Beelen D W. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 2000; 11: 344–353
   PubMed Web of Science ®Google Scholar
• Schulte C M, Beelen D W. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 2004; 103: 3635–3643
   PubMed Web of Science ®Google Scholar
• Tauchmanova L, Serio B, Del Puente A, Risitano A M, Esposito A, De Rosa G, et al. Long-lasting bone damage detected by dual-energy X-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2002; 87: 5058–5065
   PubMed Web of Science ®Google Scholar
• Crandall C. Parathyroid hormone for treatment of osteoporosis. Arch Intern Med 2002; 162: 2297–2309
   PubMed Web of Science ®Google Scholar
• Kanis J A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4: 368–381
   PubMed Web of Science ®Google Scholar
• Stern J M, Sullivan K M, Ott S M, Seidel K, Fink J C, Longton G, et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 2001; 7: 257–264
   PubMed Web of Science ®Google Scholar
• Schimmer A D, Mah K, Bordeleau L, Cheung A, Ali V, Falconer M, et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant 2001; 28: 387–391
   PubMed Web of Science ®Google Scholar
• Gandhi M K, Lekamwasam S, Inman I, Kaptoge S, Sizer L, Love S, et al. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. Br J Haematol 2003; 121: 462–468
   PubMed Web of Science ®Google Scholar
• Buchs N, Helg C, Collao C, Chapuis B, Slosman D, Bonjour J P, et al. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int 2001; 12: 880–886
   PubMed Web of Science ®Google Scholar
• Brown J P, Josse R G. Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167(10 Suppl)S1–S34, Erratum in CMAJ 2003;168:400, 676, 544
   PubMed Web of Science ®Google Scholar
• Stern J M, Sullivan K M, Ott S M, Seidel K, Fink J C, Longton G, et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 2001; 7: 257–264
   PubMed Web of Science ®Google Scholar
• Lee W Y, Baek K H, Rhee E J, Tae H J, Oh K W, Kang M I, et al. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant 2004; 34: 89–94
   PubMed Web of Science ®Google Scholar
• Kashyap A, Kandeel F, Yamauchi D, Palmer J M, Niland J C, Molina A, et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: a prospective study. Biol Blood Marrow Transplant 2000; 6: 344–351
   PubMed Web of Science ®Google Scholar
• Tauchmanova L, Selleri C, Esposito M, Di Somma C, Orio F, Jr, Bifulco G, et al. Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int 2003; 14: 1013–1019
   PubMed Web of Science ®Google Scholar
• Valimaki M J, Kinnunen K, Volin L, Tahtela R, Loyttyniemi E, Laitinen K, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 1999; 23: 355–361
   PubMed Web of Science ®Google Scholar
• Cilloni D, Carlo-Stella C, Falzetti F, Sammarelli G, Regazzi E, Colla S, et al. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 2000; 96: 3637–3643
   PubMed Web of Science ®Google Scholar
• Lee W Y, Cho S W, Oh E S, Oh K W, Lee J M, Yoon K H, et al. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 2002; 87: 329–335
   PubMed Web of Science ®Google Scholar
• Banfi A, Podesta M, Fazzuoli L, Sertoli M R, Venturini M, Santini G, et al. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer 2001; 92: 2419–2428
   PubMed Web of Science ®Google Scholar
• Withold W, Wolf H H, Kollbach S, Heyll A, Schneider W, Reinauer H. Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur J Clin Chem Clin Biochem 1996; 34: 295–299
   PubMedGoogle Scholar
• Lee W Y, Kang M I, Oh E S, Oh K W, Han J H, Cha B Y, et al. The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int 2002; 13: 62–68
   PubMed Web of Science ®Google Scholar
• Heaf J, Tvedegaard E, Kanstrup I L, Fogh-Andersen N. Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant 2003; 17: 268–274
   PubMed Web of Science ®Google Scholar
• Charopoulos I, Tournis S, Trovas G, Raptou P, Kaldrymides P, Skarandavos G, et al. Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women. J Clin Endocrinol Metab 2006; 91: 1748–1753
   PubMed Web of Science ®Google Scholar
• Compston J E. Osteoporosis after liver transplantation. Liver Transplant 2003; 9: 321–330
   PubMed Web of Science ®Google Scholar
• Carlson K, Simonsson B, Ljunghall S. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 1994; 55: 408–411
   PubMed Web of Science ®Google Scholar
• McDonald J A, Dunstan C R, Dilworth P, Sherbon K, Sheil A G, Evans R A, et al. Bone loss after liver transplantation. Hepatology 1991; 14: 613–619
   PubMed Web of Science ®Google Scholar
• Floreani A, Fries W, Luisetto G, Burra P, Fagiuoli S, Boccagni P, et al. Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg 1998; 4: 311–319
   PubMedGoogle Scholar
• Grigg A P, Shuttleworth P, Reynolds J, Schwarer A P, Szer J, Bradstock K, et al. Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2006; 91: 3835–3843
   PubMed Web of Science ®Google Scholar
• Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki M J. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 2005; 90: 3877–3885
   PubMed Web of Science ®Google Scholar
• D'Souza A B, Grigg A P, Szer J, Ebeling P R. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation. Intern Med J 2006; 36: 600–603
   PubMed Web of Science ®Google Scholar